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STATE-OF-THE-ART PAPER STATE-OF-THE-ART PAPER1169Gene Therapy for Heart FailureYoshiaki Kawase, Dennis Ladage, Roger J. Hajjar
Recent advances in the understanding of the molecular basis of myocardial dysfunction,
combined with increasingly efficient gene transfer technology, suggest that gene-based therapy
of heart failure is within reach, as argued by Kawase and colleagues. The pros and cons of
various gene transfer techniques are reviewed, and several potential targets are discussed. The
recent successful and safe completion of a phase 2 trial targeting the sarcoplasmic reticulum
calcium ATPase pump may herald a new era for gene therapy for the treatment of heart
failure.CLINICAL RESEARCH CLINICAL TRIAL
1181Remote ICD Monitoring With Automatic Clinician Alerts
May Speed Diagnosis of ArrhythmiasGeorge H. Crossley, Andrew Boyle, Holly Vitense, Yanping Chang, R. Hardwin Mead,
for the CONNECT Investigators
Current generation implantable cardioverter-defibrillators (ICDs) collect advanced diagnostics,
and some have the ability to wirelessly transmit this information with or without the patient’s
involvement. The CONNECT (Clinical Evaluation of Remote Notification to Reduce Time
to Clinical Decision) trial sought to determine whether wireless remote monitoring with
automatic clinician alerts would reduce the time from a clinical event to a clinical decision
compared with patients receiving standard in-office care. Remote monitoring did reduce the
time from clinical event to clinical decision. Automatic clinician alerts were classified by the
clinician as “meaningful” 62% of the time and “timed appropriately” 84% of the time.
Wireless remote monitoring with automatic clinician alerts may improve patient outcomes for
patients with ICDs.(continued on page A-21)
MARCH 8, 2011 (continued) A-21INTERVENTIONAL CARDIOLOGY1190GPIs Safely Reduce the Risk of Periprocedural MI After Elective PCIDavid E. Winchester, Xuerong Wen, William D. Brearley, Ki E. Park, R. David Anderson,
Anthony A. Bavry
Winchester and colleagues performed a systematic review to investigate the efficacy and safety
of glycoprotein IIb/IIIa inhibitors (GPIs) during elective percutaneous coronary intervention
(PCI). Trials that randomly assigned patients undergoing elective PCI to a GPI were
included if stents and thienopyridines were routinely used. A total of 22 studies with over
10,000 patients were included. The incidence of myocardial infarction (MI) was 5.1% with
GPI versus 8.3% with control. There were no significant differences in major bleeding, minor
bleeding, or mortality. These results confirm that in the current era of elective PCI performed
with stents and thienopyridines, GPIs provide clinical benefit.Editorial Comment: Deepak L. Bhatt, p. 1200CORONARY ARTERY DISEASE1202Reduced Mortality in Post-MI Patients Who Continue Clopidogrel After CABGRikke Sørensen, Steen Z. Abildstrøm, Peter R. Hansen, Anders Hvelplund, Charlotte Andersson,
Mette Charlot, Emil L. Fosbøl, Lars Køber, Jan K. Madsen, Gunnar H. Gislason, Christian Torp-Pedersen
Sørensen and colleagues examined the clinical efficacy of clopidogrel in patients with a recent
myocardial infarction (MI) who were revascularized with coronary artery bypass grafting
(CABG). All patients admitted with first-time MI treated with CABG within 180 days were
identified in Denmark, and their use of clopidogrel after discharge from surgery was
determined. Of the over 3,500 patients, 27% were treated with clopidogrel after CABG.
These patients had a relative risk of death of 0.59 compared with those who did not receive
clopidogrel. These results suggest that post-MI patients should receive clopidogrel for at least
1 year, even if they undergo CABG surgery.CORONARY ARTERY DISEASE1210Meta-Analysis Links Higher Potassium Intake to Reduced Cardiovascular RiskLanfranco D’Elia, Gianvincenzo Barba, Francesco P. Cappuccio, Pasquale Strazzullo
D’Elia and colleagues evaluated the relationship between dietary potassium intake and the
incidence of vascular disease by performing a meta-analysis of 11 prospective studies involving
almost one-quarter of a million participants. Potassium intake was assessed by a variety of
methods, including 24-h dietary recall, food frequency questionnaire, and 24-h urinary
excretion. In the pooled analysis, a 1.64-g (42 mmol) per day higher potassium intake was
associated with a 21% lower risk of stroke and with a trend toward lower risk of coronary
heart disease and total cardiovascular disease. These results support recommendations for
higher consumption of potassium-rich foods to prevent vascular diseases.(continued on page A-23)
MARCH 8, 2011 (continued) A-23VASCULAR DISEASE1220Subjects With PAD Have More Progression of CAD on Serial IVUS ImagingAyman A. Hussein, Kiyoko Uno, Kathy Wolski, Samir Kapadia, Paul Schoenhagen, E. Murat Tuzcu,
Steven E. Nissen, Stephen J. Nicholls
Hussein and colleagues studied the progression of coronary atherosclerosis in patients who
also have peripheral arterial disease (PAD) compared with those without PAD. Data was
collected from subjects who participated in 1 of 7 clinical trials that employed serial
intravascular ultrasound (IVUS) imaging. Patients with PAD had a greater percent atheroma
volume (PAV), more images containing calcium, and smaller vessel lumens. On serial
evaluation, patients with PAD had greater progression of PAV and experienced more
cardiovascular events. These results show that patients with both PAD and coronary artery
disease (CAD) have a more malignant disease than patients with CAD and no PAD.VASCULAR DISEASE
1226Sex Differences in Central Hemodynamics May Explain
Higher Rates of Heart Failure With Preserved Ejection Fraction in WomenChi Young Shim, Sungha Park, Donghoon Choi, Woo-In Yang, In-Jeong Cho, Eui-Young Choi,
Namsik Chung, Jong-Won Ha
Shim and colleagues studied the association between arterial stiffness and left ventricular
diastolic function in women and men by performing simultaneous echocardiography and
radial artery tonometry. The peripheral blood pressure (BP) and pulse pressure (PP) were
similar between sexes. However, central PP and augmentation index were higher and PP
amplification was lower in women. The associations of PP amplification with Em velocity
and E/Em were significant in women but not in men. Despite similar peripheral PP, the
central hemodynamics reflecting arterial stiffness are different between men and women and
may predispose women to heart failure with preserved ejection fraction.
Editorial Comment: Barry A. Borlaug, p. 1234(continued on page A-31)
MARCH 8, 2011 (continued) A-31CARDIAC IMAGING1237CCTA Provides Valuable Prognostic InformationEdward A. Hulten, Salvatore Carbonaro, Sara P. Petrillo, Joshua D. Mitchell, Todd C. Villines
While the diagnostic accuracy of cardiac computed tomography angiography (CCTA) has
been established, its prognostic value for predicting outcomes is less well established. Hulten
and colleagues performed a meta-analysis of 18 studies that enrolled almost 10,000 subjects
with a median follow-up of 20 months. The pooled annualized event rate for major adverse
cardiac events was 8.8% for patients with obstructive disease (any vessel with 50% luminal
stenosis) compared with 0.17% for those with a normal CCTA. These data demonstrate that
a normal CCTA conveys a very low risk for future death, myocardial infarction, or coronary
revascularization, with an annual event rate comparable to an otherwise healthy population.
